Navigation Links
Research network wins approximately £5.7 million to target human and animal diseases in Africa
Date:7/1/2009

in low- and middle-income countries.

SACIDS' work tackles a woefully under-resourced and important sector. Most major infectious human diseases have animal origins and up to 80 per cent of emerging infectious human diseases come from livestock or wild animals, yet Africa currently has the least capacity to survey major livestock or wildlife diseases. Livestock provide a vital source of nutrition, financial security and status in the continent, but livestock production is severely limited by disease. Many of the world's worst livestock diseases, such as Foot and Mouth disease, are indigenous to Africa.

The Wellcome Trust grant will provide funds for SACIDS to:

  • Develop and deliver new MSc courses in critical areas of Molecular Biology and Epidemiology
  • Develop biosafety systems and quality management in laboratories
  • Develop continuing professional development to upgrade skills
  • Develop a secure internet-based technology platform for partners to share resources
  • Enhance ICT support to distance learning
  • Provide research apprenticeships with 'smart partners' institutions, namely RVC and LSHTM

Professor Mark Rweyemamu, Executive Director of SACIDS, Professor at Sokoine University and a Visiting Professor at RVC, stressed the necessity of the SACIDS initiative. He said: "The 'one health' collaboration between medical and veterinary sectors helps us to focus our common resources to study the shared problem of infectious disease. The 'smart partnership' between SACIDS and the LIDC colleges will marshal the best science expertise to the study of infectious diseases in the endemic setting and to identify new and emerging diseases early". Professor Jeff Waage, Director of LIDC, said "LIDC's member institutions are excited at the prospect of building a 'one health' platform for research and training with SACIDS members in Africa."

SACIDS has also won financial backing for analysis
'/>"/>

Contact: Guy Collender
guy.collender@lidc.bloomsbury.ac.uk
020-795-88260
London School of Hygiene & Tropical Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...Call/ -- Quest Diagnostics Incorporated (NYSE: DG...sting, information and services, announced that fo...me from continuing operations rose to $192 million...r $0.81 per diluted share, for the third quarter o...d by a $0.03 per share charge associated with the ...
(Date:11/4/2009)...- GenVault Corporation, the leader in ambient temp..., medicine and identification, today announced tha...O, will be presenting at the BIOCOM Investor Confe...Jolla, CA. ,, During the presentation, Dr. Well...r with recent customer, technical and strategic de...
(Date:11/4/2009)... GenVault Corporation (Carlsbad, CA) today announc... Board of Directors. Dr. Brody, the Irwin Jacobs ...claimed physician-scientist and university leader....erved as president of The Johns Hopkins University...eering and the Institute of Medicine, and is renow...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Consumer Watchdog to Obama 3A Dont Sacrifice Malpractice Victims in the Name of Health Care Reform 56653 1Consumer Watchdog to Obama 3A Dont Sacrifice Malpractice Victims in the Name of Health Care Reform 56653 2Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 1Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 2Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 3Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 4 243 5 million NIH grant supports AIDS vaccine research at UC Santa Cruz 56648 1 243 5 million NIH grant supports AIDS vaccine research at UC Santa Cruz 56648 2 243 5 million NIH grant supports AIDS vaccine research at UC Santa Cruz 56648 3
... available in French . , , PRINCE GEORGE, B.C. ...nister of Natural Resources, Dick Harris, Member o...nced that Canadas New Governments Mountain Pine Be...o help communities, including First Nations, deal ...cedented beetle infestation in British Columbia. ,...
...lice discovered about 50 tons of rotten meat on th... risk of rotten meat turning up in grocery stores ...ance of efficient food quality monitoring is clear...nable large numbers of samples to be analysed quic...order to make comprehensive monitoring a reality. ...
...information we put in our heads" The answer: a lot...,000 words. And then there are all the little deta...p in, the time we spilled orange juice on our test...equation (for some of us). , So where do we put i...wer would be easy: we would store memories as 0s a...
Other Biology News:Mountain pine beetle: Canada's new government delivers 2New method reveals substances on surfaces of any kind 2A balanced memory network 2
(Date:11/6/2009)...wire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE... John Docherty, president and chief operating offi...nual Investor Summit on November 10, 2009 at 4:00 ...herty will provide an overview of the Company,s le...ical Interferon Alpha-2b. The slide show portion ...
(Date:11/6/2009)...stCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ...nced updated results from a Phase II study of intr...static to the lung in a poster presentation at the...eting held in Miami Beach, Florida, from November ...hase II Study of Intravenous REOLYSIN (Wild-type R...
(Date:11/5/2009)...wswire/ -- The endangered black-footed ferrets inh...are carnivore feeds on prairie dogs. The prairie...ire population die-offs in towns occur. The U.S. ...a ferret breeding program and has been releasing t... habitat. Unfortunately, plague can sweep through...
(Date:11/5/2009)...-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Bo...he quarter ended September 30, 2009. The Company,s...t follow. ,, Third Quarter 2009 ,, The Com...share for the third quarter of 2009 as compared to... third quarter of 2008. ,, Net sales were $5.0...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...harmaceuticals Founder and Senior Management Form ... Podiatry Markets, FAIRFIELD, N.J., May 13 Medim...t commenced operations. The newly-formed,Company, ...eam of the,former Bradley Pharmaceuticals (NYSE: ...ovative prescription products for the Dermatology ...
...TY, May 13 /PRNewswire-FirstCall/ - AEterna Zentar...armaceutical company focused on,endocrine therapy ...led,"Placebo-controlled dose-ranging Phase 2 study...trorelix in patients with symptomatic benign,prost...ication in an,upcoming issue of the European Urolo...
... and TUCSON, Ariz., May 12 ,University-affiliated ...,crucial in creating opportunities for sustainable...s the globe. Experts in park development,will gath...the best,practices and emerging trends in maximizi...echnology development., BioParks 2008, a joint m...
Other Biology Technology:Medimetriks Pharmaceuticals, Inc. Begins Operations 2AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 2AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 3AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 4AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 5AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 6University Research and Science Parks Create Sustainable Innovation 2
...e NOVOstar is an exciting product for cell-based k..., cell-based assays required the use of expensive ... for scientists in the assay development stage. Th...r cell-based assays as well as any other assay sui...
...e Digital Clamp One can operate as a Voltage Clamp... Clamp in electrophysiology research applications....ional analog equipment. • This amazing in...in the capabilities of Digital Signal Processing (...
Dispensing Bins from Terra Universal, Inc.
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
Biology Products: